Yin, M., Dhir, R., & Parwani, A. V. (2007). Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma. BioMed Central.
Chicago ZitierstilYin, Ming, Rajiv Dhir, und Anil V. Parwani. Diagnostic Utility of P501s (prostein) in Comparison to Prostate Specific Antigen (PSA) for the Detection of Metastatic Prostatic Adenocarcinoma. BioMed Central, 2007.
MLA ZitierstilYin, Ming, Rajiv Dhir, und Anil V. Parwani. Diagnostic Utility of P501s (prostein) in Comparison to Prostate Specific Antigen (PSA) for the Detection of Metastatic Prostatic Adenocarcinoma. BioMed Central, 2007.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.